Andrew MacIntyre

About Andrew MacIntyre

With a leadership background of over 20 years’ experience developing and managing pre-clinical and clinical programs, in a wide variety of international CRO and Pharma environments; working in a broad variety of therapeutic areas including many Immuno-Oncology / Immunotoxicology programs. I have led development programs for a wide range of biotherapeutics; all at various levels of GxP (GLP, GCPL, GCPv and GMP) as well as CAP / CLIA. I have successfully led worldwide translational strategies with a number of CRO over the past 20 years working on at least 30 major drug development programs (from early development through to late clinical phases); ensuring profitability, meeting client needs, and exceeded expectations for both internal and external clients, through both strategic and tactical use of services. I have also actively led both national and international facilities.

Experience

1. Senior Director, Global Alliance Management

   Precision For Medicine

   Jan 2021 — Present · Seattle, WA, US

   Contract management: Managing contractual obligations, such as milestone payments; advising collaboration participants on how the partnership contract should be implemented; and if necessary, negotiating with the partner regarding the interpretation of the contract in the event of a difference of opinion between the two sides. Progress monitoring: Tracking progress, including coordinating the definition and reporting of the KPIs, as well as leading periodic health checks. Process management: Establishing and ensuring smooth operation of the collaboration ground rules, such as the protocol for formal governance meetings and procedures for decision making, project team meetings, data exchange, and other kinds of interactions. Brand management: Managing how the company is perceived by partners, and how the partnership is perceived by people in Precision. Alignment and relationship building: Leading efforts to increase alignment, mutual understanding, and trust between collaboration participants, including activities such as the kickoff event and periodic collaboration team events. Strategic value and risk management: Identifying the important value drivers and key risks, ensuring those involved do not lose focus on strategic aspects, and leading efforts to mitigate risks and accelerate value creation; may also include looking for win-win opportunities to extend the relationship by expanding the existing partnership or creating additional spin-off collaborations. Change management: Anticipating upcoming changes in project stages or collaboration participants, managing transitions smoothly, and serving as the partnership’s memory, as well as facilitating complex discussions with the partner to map a way forward when unanticipated situations or corporate decisions in either party trigger the need for change.

Education

• University of Liverpool

  PhD, Veterinary Pathology

• Liverpool John Moores University

  BSc, Applied Biology

• University of Liverpool

  MB ChB, Medicine

• The Manchester Metropolitan University

  Master’s Degree, Immunology, Distinction